Cellular Protrusions Engage Viral Infection Enhancing EF-C Peptide Nanofibrils

Desirée Schütz, Sascha Rode, Clarissa Read, Janis A. Müller, Bernhard Glocker, Konstantin M. J. Sparrer, O. Fackler, Paul Walther, Jan MünchbioRxiv 2020 · DOI

Abstract

Self-assembling peptide nanofibrils (PNF) have gained increasing attention as versatile molecules in material science and biomedicine. One important application of PNF is to enhance retroviral gene transfer, a technology that has been central to the development of gene therapy. The best-investigated and commercially available PNF is derived from a 12-mer peptide termed EF-C. The mechanism of transduction enhancement depends on the polycationic surface of EF-C PNF, which binds to the negatively charged membranes of viruses and cells, thereby overcoming electrostatic repulsion and increasing virion attachment and fusion. Assuming an even distribution of charges at the surfaces of virions and cells would result in an evenly distributed interaction of the virions with the cell surface. However, we here report that PNF do not randomly bind at the cell surface but are actively engaged by cellular protrusions. Chemical suppression of protrusion formation in cell lines and primary CD4+ T cells greatly reduced fibril binding and hence virion binding. Thus, the mechanism of PNF-mediated viral transduction enhancement involves active engagement of virus-loaded fibrils by cellular protrusions.

Introduction

Retroviral gene transfer is a cornerstone of modern medicine, particularly in the production of CAR-T cells for cancer therapy. However, achieving efficient viral entry is challenging because both viral and cellular membranes carry negative charges, leading to electrostatic repulsion. To overcome this, researchers use transduction enhancers like EF-C peptide nanofibrils (PNFs).

While it was previously thought that these positively charged "nanosticks" acted as simple passive bridges between the virus and the cell, this study reveals a more dynamic process. The authors investigated why PNFs are significantly more effective than simple polycations like Polybrene, focusing on the physical dynamics at the cell-surface interface.

Visualizing the Active Engagement of Nanofibrils

Using high-resolution Scanning Electron Microscopy (SEM) and Scanning Transmission Electron Microscopy (STEM) tomography, the researchers observed that EF-C PNFs do not distribute randomly. Instead, they are specifically captured by cellular protrusions such as filopodia and lamellipodia.

SEM and STEM imaging of HeLa, Jurkat, and CD4+ T cells showing EF-C PNF (red arrows) localized on cellular protrusions.

As seen in the imaging above, the fibrils (indicated by red arrows) are actively engaged by the cell's "tentacles." Time-lapse microscopy further confirmed that filopodia reach out, grab these fibrils, and pull them toward the cell body within minutes. This structural "handle" provided by the fibrillar superstructures explains why PNFs outperform soluble polymers, which lack the architecture to be actively captured.

Quantitative Impact of Protrusion Inhibition

To confirm the necessity of these protrusions, the team used Dynasore, a dynamin inhibitor that suppresses the formation of filopodia and lamellipodia. The impact was measured across multiple cell models, including HeLa cells, Jurkat T cells, and primary human CD4+ T cells.

Flow cytometry analysis showing reduced EF-C PNF binding (percentage of cells and Mean Fluorescence Intensity) in HeLa, Jurkat T, and CD4+ T cells following Dynasore treatment.

Quantitative analysis via flow cytometry showed that inhibiting protrusion formation led to a dramatic drop in fibril binding. In Jurkat and primary T cells, binding decreased from approximately 50-60% of cells to just 10-20%. Furthermore, while EF-C PNFs typically increase viral attachment to HeLa cells by a factor of 4.3x, this enhancement was nearly abolished when cellular protrusions were inhibited.

Conclusion and Future Directions

This study shifts the paradigm of viral transduction enhancement from a passive electrostatic model to an active biological process. Cells utilize their natural machinery for environmental sensing and capture to engage virus-loaded nanofibrils.

One remaining question for clinical application is the intracellular fate of these fibrils. Understanding whether these synthetic structures persist within modified cells after they are returned to patients is a critical safety consideration for future gene therapy research. Additionally, the discovery that "stressed" cells (e.g., during shRNA transduction) increase protrusion formation suggests that the efficiency of gene therapy might be inherently linked to the physiological state of the target cells.

Summary updated

Abstract

Abstract Self-assembling peptide nanofibrils (PNF) have gained increasing attention as versatile molecules in material science and biomedicine. One important application of PNF is to enhance retroviral gene transfer, a technology that has been central to the development of gene therapy. The best-investigated and commercially available PNF is derived from a 12-mer peptide termed EF-C. The mechanism of transduction enhancement depends on the polycationic surface of EF-C PNF, which binds to the negatively charged membranes of viruses and cells thereby overcoming electrostatic repulsion and increasing virion attachment and fusion. Assuming an even distribution of charges at the surfaces of virions and cells would result in an evenly distributed interaction of the virions with the cell surface. However, we here report that PNF do not randomly bind at the cell surface but are actively engaged by cellular protrusions. Chemical suppression of protrusion formation in cell lines and primary CD4+ T cells greatly reduced fibril binding and hence virion binding. Thus, the mechanism of PNF-mediated viral transduction enhancement involves active engagement of virus-loaded fibrils by cellular protrusions.
BibTeX
@misc{schutz2020cellular,
  author = {Desirée Schütz and Sascha Rode and Clarissa Read and Janis A. Müller and Bernhard Glocker and Konstantin M. J. Sparrer and O. Fackler and Paul Walther and Jan Münch},
  title = {{Cellular Protrusions Engage Viral Infection Enhancing EF-C Peptide Nanofibrils}},
  year = {2020},
  doi = {10.1101/2020.10.01.321810},
  howpublished = {bioRxiv},
}
Figure